Literature DB >> 20956817

Ductal carcinoma in situ: terminology, classification, and natural history.

D Craig Allred1.   

Abstract

Ductal carcinoma in situ (DCIS) refers to breast epithelial cells that have become "cancerous" but still reside in their normal place in the ducts and lobules. In this setting, cancerous means that there is an abnormal increase in the growth of the epithelial cells, which accumulate within and greatly expand the ducts and lobules. DCIS is a nonlethal type of cancer because it stays in its normal place. However, DCIS is very important because it is the immediate precursor of invasive breast cancers, which are potentially lethal. This article provides a general overview of DCIS, including historical perspective, methods of classification, current perspective, and future goals.

Entities:  

Mesh:

Year:  2010        PMID: 20956817      PMCID: PMC5161057          DOI: 10.1093/jncimonographs/lgq035

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  39 in total

1.  Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

Authors:  P O'Connell; V Pekkel; S A Fuqua; C K Osborne; G M Clark; D C Allred
Journal:  J Natl Cancer Inst       Date:  1998-05-06       Impact factor: 13.506

2.  Cancer risk assessment in benign breast biopsies.

Authors:  D L Page
Journal:  Hum Pathol       Date:  1986-09       Impact factor: 3.466

3.  The classification of ductal carcinoma in situ and its association with biological markers.

Authors:  L G Bobrow; L C Happerfield; W M Gregory; R D Springall; R R Millis
Journal:  Semin Diagn Pathol       Date:  1994-08       Impact factor: 3.464

4.  Long-term follow-up of in situ carcinoma of the breast.

Authors:  V Eusebi; E Feudale; M P Foschini; A Micheli; A Conti; C Riva; S Di Palma; F Rilke
Journal:  Semin Diagn Pathol       Date:  1994-08       Impact factor: 3.464

5.  The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.

Authors:  Melinda E Sanders; Peggy A Schuyler; William D Dupont; David L Page
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

Review 6.  The natural history of ductal carcinoma in situ of the breast: a review.

Authors:  Bircan Erbas; Elena Provenzano; Jane Armes; Dorota Gertig
Journal:  Breast Cancer Res Treat       Date:  2005-12-01       Impact factor: 4.872

Review 7.  Ductal carcinoma in situ--current management.

Authors:  Martin J O'Sullivan; Monica Morrow
Journal:  Surg Clin North Am       Date:  2007-04       Impact factor: 2.741

8.  Intraductal carcinoma of the breast: follow-up after biopsy only.

Authors:  D L Page; W D Dupont; L W Rogers; M Landenberger
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

9.  Molecular markers in ductal carcinoma in situ of the breast.

Authors:  Dale Porter; Jaana Lahti-Domenici; Aparna Keshaviah; Young Kyung Bae; Pedram Argani; Jeffrey Marks; Andrea Richardson; Amiel Cooper; Robert Strausberg; Gregory J Riggins; Stuart Schnitt; Edward Gabrielson; Rebecca Gelman; Kornelia Polyak
Journal:  Mol Cancer Res       Date:  2003-03       Impact factor: 5.852

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  57 in total

1.  Digital breast tomosynthesis: computer-aided detection of clustered microcalcifications on planar projection images.

Authors:  Ravi K Samala; Heang-Ping Chan; Yao Lu; Lubomir M Hadjiiski; Jun Wei; Mark A Helvie
Journal:  Phys Med Biol       Date:  2014-11-13       Impact factor: 3.609

Review 2.  Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.

Authors:  Ashley G Rivenbark; Siobhan M O'Connor; William B Coleman
Journal:  Am J Pathol       Date:  2013-08-27       Impact factor: 4.307

3.  Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.

Authors:  Anna K Casasent; Aislyn Schalck; Ruli Gao; Emi Sei; Annalyssa Long; William Pangburn; Tod Casasent; Funda Meric-Bernstam; Mary E Edgerton; Nicholas E Navin
Journal:  Cell       Date:  2018-01-04       Impact factor: 41.582

4.  BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.

Authors:  Inês Godet; Daniele M Gilkes
Journal:  Integr Cancer Sci Ther       Date:  2017-02-27

Review 5.  Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.

Authors:  Vidya C Sinha; Helen Piwnica-Worms
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

6.  Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain.

Authors:  Laia Domingo; Anabel Romero; Francesc Belvis; Mar Sánchez; Joana Ferrer; Dolores Salas; Josefa Ibáñez; Alfonso Vega; Francesc Ferrer; M Soledad Laso; Francesc Macià; Xavier Castells; Maria Sala
Journal:  Eur Radiol       Date:  2011-05-11       Impact factor: 5.315

Review 7.  [Diagnostic imaging of breast cancer : An update].

Authors:  M Funke
Journal:  Radiologe       Date:  2016-10       Impact factor: 0.635

8.  Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014.

Authors:  Marc D Ryser; Laura H Hendrix; Mathias Worni; Yiling Liu; Terry Hyslop; E Shelley Hwang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-11       Impact factor: 4.254

9.  A metabolic profile of routine needle biopsies identified tumor type specific metabolic signatures for breast cancer stratification: a pilot study.

Authors:  Narumi Harada-Shoji; Tomoyoshi Soga; Hiroshi Tada; Minoru Miyashita; Mutsuo Harada; Gou Watanabe; Yohei Hamanaka; Akiko Sato; Takashi Suzuki; Akihiko Suzuki; Takanori Ishida
Journal:  Metabolomics       Date:  2019-11-04       Impact factor: 4.290

10.  Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.

Authors:  Nicolien T van Ravesteyn; Jeroen J van den Broek; Xiaoxue Li; Harald Weedon-Fekjær; Clyde B Schechter; Oguzhan Alagoz; Xuelin Huang; Donald L Weaver; Elizabeth S Burnside; Rinaa S Punglia; Harry J de Koning; Sandra J Lee
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.